Biotech company develops innovative cancer treatments combining CAR T-cell therapy with targeted antibodies for liquid and solid tumors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Biosceptre is a biotechnology company focused on developing innovative cancer therapies, particularly through its BRiDGECAR™ system. This system combines universal CAR T-cell therapy with targeted antibodies, aiming to treat a wide range of cancers. The company’s goal is to provide new treatment options for patients suffering from both liquid and solid tumors.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Biosceptre Management Team
Biosceptre Valuations & Financials
View real-time NPM data on Biosceptre stock including daily Biosceptre stock price estimates, valuation history, and historical share price information. Access Biosceptre financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Biosceptre pricing across six independent market signals. Looking for private company due diligence data sources on Biosceptre? Get in touch to learn more.
Similar Companies
like Biosceptre
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Typeface
AI & Machine Learning
Generates personalized, on-brand content across text and visuals while preserving brand identity at scale.
Delivery Collective
Commerce & Marketplaces
A platform that enables restaurants to accept direct online orders, bypassing high commission fees, and offers fast, reliable delivery services.
GT metabolic
Healthcare & Life Sciences
Delivering incisionless, magnetic-driven tissue healing to transform bariatric surgery with safer, reversible surgical connections.
Workweek
Media & Entertainment
Empowers professionals with expert insights and peer-driven communities to streamline decision-making and elevate daily operations.
KromaTiD
Healthcare & Life Sciences
Delivering single-cell cytogenetic clarity for gene editing and cell therapies with high-confidence genome integrity analysis.
Serval
Enterprise Software
AI-native IT service management platform that combines help desk, access management, and workflow automation into a single solution.
NimbleBox
AI & Machine Learning
Enables AI development that empowers teams to train, deploy, and manage machine-learning workflows in one plug-and-play platform.
Endeavor Bank
FinTech
Delivers advisory banking and financial tools that empower businesses and individuals.
FAQ
We have answers
Biosceptre stock does not trade on public stock exchanges. Biosceptre stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Biosceptre stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Biosceptre Stock does not trade on public stock exchanges. In order to sell Biosceptre shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Biosceptre does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Biosceptre share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Biosceptre stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Biosceptre stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Biosceptre stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Biosceptre is a private company and has not had an IPO. There is currently no Biosceptre IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Biosceptre IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
